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Abstract 
Protein phosphorylation is a crucial posttranslational modification for regulating cellular 
processes in bacteria; however, it has not been extensively studied because of technical 
difficulties in the enrichment of phosphopeptides. We devised an enrichment protocol that 
enabled the identification of >1,000 phosphopeptides from a single bacterial sample. We 
discovered three high-confidence serine and threonine phosphorylation motifs, as well as 29 
other motifs at various levels of confidence, from three distinct bacterial phosphoproteomes. 
We found that the proline-directed and basophilic phosphorylation motifs that are commonly 
enriched in eukaryotes were not observed in bacteria. Unlike eukaryotes, bacteria had a low 
occurrence of both phosphorylation and acetylation within N-terminal phosphopeptides. 
Because infection of host cells by bacterial pathogens is often accompanied by 
kinase-mediated phosphorylation events, the differences in phosphorylation preferences 
between bacteria and eukaryotes revealed by this study could be useful in identifying 
bacterial-specific targets for future therapies. 
 Introduction 
The phosphorylation of serine, threonine, and tyrosine in proteins is as important for bacteria 
as it is for other living organisms (1). Accumulating evidence suggests that protein 
phosphorylation serves as a fundamental regulatory mechanism in nearly all physiological 
processes in bacteria, especially in key steps of the infection process, such as adhesion to the 
host, perturbation of host signaling cascades, and impairment of host defense mechanisms (2, 
3). Because of the close link between the dysregulation of phosphorylation and various 
human pathologies, phosphorylation mechanisms are expected to be promising targets for 
new drugs able to overcome antibiotic resistance (4, 5). Phosphoproteomic analysis has 
emerged as a promising tool for studying variations in protein phosphorylation in eukaryotic 
cells (6); however, the much lower degree of protein phosphorylation in bacteria (about 80 
times less than that in eukaryotes) has severely hampered progress (7). 
 
In 2007, Macek et al. were the first to evaluate the site-specific bacterial phosphoproteome in 
Bacillus subtilis with strong cation exchange chromatography and titanium dioxide (TiO2) 
enrichment coupled with high-accuracy mass spectrometry to identify phosphopeptides in the 
low-femtomole range (8). This approach has been applied to a number of bacteria, including 
Escherichia coli (9, 10), Lactococcus lactis (11), Halobacterium salinarum (12), and 
pathogenic Klebsiella pneumoniae (13). The method of Macek et al. has become a standard 
procedure in bacterial phosphoproteomics, and on average, around 100 phosphorylation sites 
can be detected in each organism with 10 mg of starting protein under a given growth 
condition. Although the identified phosphorylated residues are better conserved than random 
residues, the phosphorylation sites in published phosphoproteome datasets have extremely 
low overlap, even within the same bacterial species (7, 9, 10). Therefore, the published 
phosphoproteomes are certainly incomplete, and may be missing many low-occupancy sites 
because of the technical limitations of current approaches. 
 
Here, we present a protocol for the highly sensitive enrichment of phosphopeptides, together 
with its application for studying the phosphoproteomes of three distinct bacterial species, E. 
coli, B. subtilis, and K. pneumoniae, with enhanced phosphopeptide identification and 
coverage (14-16). The resulting large-scale bacterial phosphoproteome resource has enabled 
us to uncover various bacterium-specific phosphorylation features, including high-confidence 
phosphorylation motifs and the notably low coincidence of N-terminal acetylation and 
phosphorylation. In addition, neither proline-directed nor eukaryote-type basophilic 
phosphorylation motifs were enriched in bacteria. Given these bacterium-specific 
phosphorylation signatures, bacteria might have alternative kinase-recognition mechanisms 
that could be used as targets for the development of new therapeutic drugs. 
Results 
Design and development of a highly sensitive approach to analyze the bacterial 
phosphoproteome 
The extremely low degree of protein phosphorylation and the presence of many anionic 
biomolecules, such as phospholipids, peptidoglycans, and lipid A, present a substantial 
technical challenge to the analysis of bacterial phosphoproteomes (17-22). To address this, 
we first developed a large-scale aliphatic hydroxy acid–modified metal oxide 
chromatography (HAMMOC) protocol coupled with liquid chromatography with tandem 
mass spectrometry (LC-MS/MS) to accommodate an up to five-fold increase in the amount of 
sample by increasing the amount of TiO2 as well as the tip size. We also examined three 
different methods of pretreating the samples, including ultrafiltration, precipitation with 
acetone, and precipitation with methanol and chloroform. All of these methods increased the 
number of phosphopeptides that we identified compared with that in the absence of 
pretreatment (about 70), and precipitation with methanol and chloroform provided more than 
300 phosphopeptides (Fig. 1A). Some biomolecules derived from E. coli interfered with and 
markedly suppressed the HAMMOC-based enrichment, because the lysate from untreated E. 
coli showed the highest intensity in total ion current (TIC) chromatograms, but the lowest 
number of identified phosphopeptides (fig. S1). 
 
Because precipitation by methanol and chloroform was the most effective of the three 
procedures for removing interfering components, it was used in subsequent experiments. To 
refine the enrichment conditions for bacteria, a series of sample amounts ranging from 500 to 
1,000 µg was evaluated. The number of observed phosphopeptides increased with increasing 
sample size, which was expected given that the maximum capacity of large-scale HAMMOC 
is approximately 800 to 900 µg (Fig. 1B). Accordingly, we suggest that our large-scale 
HAMMOC procedure is applicable to bacterial phosphoproteome analysis without sample 
fractionation (8-10), and the small sample size requirement [20 times less than that required 
for conventional procedures (>10 mg)] is particularly advantageous for clinical purposes. 
 
Characterization of the phosphoproteome map of E. coli as a model gram-negative 
organism 
Our developed strategy yielded the most comprehensive E. coli phosphoproteome to date; a 
total of 1,212 phosphopeptides in 392 phosphoproteins with 1,088 phosphosites (Fig. 2A and 
table S1). After assessing phosphosite localization by site localization probability based on 
the posttranslational modification (PTM) score (23-25) and the Mascot delta score (23-26), 
and by the presence of site-determining ions (27), 766 phosphosites were retained as 
high-confidence sites (table S1). In comparison with previous studies, in which about 150 
phosphopeptides were determined from five growth conditions, we obtained about eight-fold 
more identified phosphopeptides, with a similar distribution of phosphosites; that is, 69.5% 
phosphorylated serine (pSer), 21.8% phosphorylated threonine (pThr), and 7.7% 
phosphorylated tyrosine (pTyr) (table. S1) (9, 10). Furthermore, our results showed large 
overlaps with published E. coli phosphoproteomes at the levels of both phosphopeptide and 
phosphoprotein (Fig. 2, A and B). For example, all of the reported phosphorylated ribosomal 
proteins in previous phosphoproteomes were included in our dataset (Fig. 2C) (9, 10). The 
high overlap between the previously reported E. coli phosphoproteomes and ours supports the 
validity of our developed approach. 
 
In the Ecogene database, about 7% of the genome of E. coli K12 strain is annotated as 
essential genes, and our results suggest that almost 30% of the proteins encoded by essential 
genes were phosphorylated (Fig. 3A), supporting a major role for protein phosphorylation in 
bacteria. Similar to other bacteria, E. coli contained phosphoproteins that are widely localized 
from the cell wall to the cytosol, suggesting that our method has no bias with respect to 
protein localization (Fig. 3B). Based on functional analysis by the bioinformatics resource 
DAVID, protein phosphorylation participates extensively in various cellular functions in E. 
coli, including central carbon metabolism and housekeeping processes, such as DNA 
metabolism, transcription, and translation (Fig. 3B). For example, the phosphoproteins that 
we identified in E. coli were overrepresented in the glycolysis pathway and among ribosomal 
proteins (Fig. 3, C and D). Almost all of the proteins that participate in the glycolysis and 
gluconeogenesis pathways were phosphorylated in E. coli. 
 
We detected some phosphorylated histidine (pHis) and phosphorylated aspartate (pAsp) 
residues, although they were labile under acidic conditions (fig. S2). Among them, pHis15 of 
phosphocarrier protein HPr (PtsH) was previously reported (28), and phosphorylation at this 
site is essential for the enzymatic activity of PtsH. Multidrug resistance protein MdtB, a 
component of the heterotrimeric efflux transporter complex, was phosphorylated on Asp649, 
whereas galactitol-specific phosphotransferase enzyme IIB component protein (GatB), which 
forms part of the phosphotransferase system, was phosphorylated on His30. Protein 
phosphorylation at these sites might modulate the biological functions of the modified 
proteins, especially for MtdB, which forms a tripartite complex with MdtA and MtdC and 
confers resistance to the novobiocin and deoxycholate (29). Indeed, many pSer- or 
pThr-containing phosphoproteins were also observed among phosphotransferases or 
two-component systems that were previously thought to be phosphorylated only on histidine, 
cysteine, or aspartate (fig. S2). 
 
Hansen et al. introduced immunoprecipitation of pTyr-containing proteins to study 
phosphotyrosine proteomics in E. coli in the stationary phase (30). The sequences 
surrounding pTyr in our study varied greatly from those found by Hansen et al., especially in 
the case of regions preceding the pTyr residue (Fig. 3E). These differences might be because 
of differences in sample state or the enrichment approaches used. Consequently, the 
combined results of these two studies provide the most comprehensive bacterial 
phosphotyrosine proteome that is currently available. 
 
Construction of other model bacterial phosphoproteome maps 
Because the phosphorylation content and cellular components among different bacterial 
species are distinct, we also applied our strategy to another gram-negative bacterium, K. 
pneumoniae, as well as to a gram-positive model bacterium, B. subtilis. For B. subtilis, 441 
phosphopeptides were observed in 175 phosphoproteins in 11 LC-MS/MS runs. Among 339 
identified phosphosites, 226 were confidently identified, with a distribution of 74.8% pSer, 
17.7% pThr, and 7.1% pTyr (table S2). On the other hand, for K. pneumoniae, we identified 
663 phosphopeptides containing 559 phosphosites, of which 388 were confidently identified. 
The phosphosite distribution was 72.9% pSer, 13.7% pThr, and 12.9% pTyr in 286 
phosphoproteins (table S3). These phosphorylation events, as expected, were mostly 
associated with central carbon metabolism (Fig. 3C). The large numbers of phosphopeptides 
discovered with our strategy should be helpful in developing a global view of the bacterial 
phosphoproteome and in elucidating the roles of phosphoregulation in bacteria (8, 13). These 
results further confirm the feasibility of our strategy for the broad identification of the 
phosphoproteome by coupling sample pretreatment and a large-scale HAMMOC protocol (8, 
9, 13). 
 
To confirm the validity of our earlier results, we further analyzed the reproducibility of our 
protocol. We found that duplicate sample preparations generated similar numbers (Fig. 1B) 
and that triplicate technical replicates of a given preparation gave a median RSD of 18.2% for 
the peak area of 224 phosphopeptides (table S5). The scatter plots from duplicate LCMS runs 
(fig. S4A) and of the triplicate technical replicates (fig. S4, B to D) showed a similar 
distribution, suggesting that our protocol is reproducible. We found that the removal of some 
interfering biomolecules by protein precipitation improved the identification of 
phosphopeptides; however, the efficiency of this method varied among different species (fig. 
S5A), and the underlying influencing factors are still not clear. Different cell components 
such as the high lipopolysaccharide (LPS) content in gram-negative bacteria, the high 
peptidoglycan content in B. subtilis, and the acidic capsule in K. pneumoniae might all affect 
the efficiency of phosphopeptide enrichment. Therefore, the method of sample pretreatment 
could be further optimized or modified to improve the phosphoproteomic analysis of other 
bacteria. In addition, we noted that the lower coverage of the phosphoproteomes of K. 
pneumoniae and B. subtilis compared with that of E. coli might not be a result of the reduced 
number of LC-MS/MS runs (26 runs in E. coli, 15 runs in K. pneumoniae, and 11 runs in B. 
subtilis), because the cumulative number of unique phosphopeptides had reached saturation 
(fig. S5B), and the total number of unique phosphopeptides in E. coli is much greater than 
that in other two bacteria. Note also that different culture conditions and different nutrients 
may provide an extended coverage of bacterial phosphoproteomic maps (10, 30-32). 
 
Identification of distinct bacterial phosphorylation features 
Because of the large in vivo bacterial phosphoproteome dataset that we obtained, we were 
able to start addressing kinase-substrate preferences. The sequence surrounding the 
phosphorylation site usually plays a critical role in kinase-substrate specificity, so this 
information would be useful for the prediction of phosphorylation sites (33-35) or for 
designing new drugs to target bacterial kinases (4, 36). So far, no high-confidence motif for 
pSer, pThr, or pTyr in bacteria has been reported, although five weak pTyr motifs in E. coli 
O157 and one pThr motif in M. tuberculosis have been identified at lower confidence levels 
(30, 37). Here, we found three previously uncharacterized high-confidence motifs. We also 
found a further 29 weak motifs including pSer, pThr, and pTyr (table S4). 
 
Our results suggest that bacterial phosphorylation motifs are quite distinct from those in 
eukaryotes; for example, the proline-directed motif and the typical eukaryote-type basophilic 
motifs that are usually enriched in eukaryotes were not observed in bacteria with either strong 
or weak confidence (Fig. 4 and table S4). Instead, bacteria have one linear sequence motif 
and position-directed motifs in which the phospho-acceptor residues are near the N terminus 
or C terminus of the protein. Acidic motifs, the common phosphorylation motif in eukaryotes, 
were also found in bacteria at a lower confidence level, suggesting that some phosphorylation 
mechanisms or kinases may be common to both bacteria and eukaryotes. 
 
It is of interest to know whether the suggested position-directed motifs found in this study are 
evolutionarily conserved. Across 11 evolutionarily divergent species, the occurrence of 
phosphorylation in the second amino acid position in the N terminus has gradually decreased 
during evolution, accounting for 6.71, 6.12, and 4.64% of the identified phosphoproteins in B. 
subtilis, E. coli, and K. pneumoniae, respectively, upon normalization to the content of Ser2 
and Thr2 at the proteome level (Fig. 5), whereas the corresponding value in mammals is ~2%. 
In addition, up to 95.8% of the N-terminal phosphopeptides in E. coli and 100% of those in B. 
subtilis and K. pneumoniae were found in proteins whose first methionine was removed 
(tables S1, S2, and S3), suggesting that the phosphorylation preference is position-dependent. 
Moreover, in comparison to that in eukaryotes, the prevalence of the co-occurrence of 
N-terminal phosphorylation and acetylation at the penultimate position was low in bacteria, 
amounting to 0, 7.7, and 8.3% of N-terminal acetylation in N-terminal phosphoproteins in B. 
subtilis, K. pneumoniae, and E. coli, respectively; the sum of N-terminal acetylation together 
with N-terminal phosphorylation accounts for 0.36 and 0.51% of the total phosphoproteins in 
K. pneumoniae and E. coli, respectively (Fig. 5) (12, 38-42). The trend appears to be 
correlated with evolutionary progression, in that there is a large increase in co-occurrence of 
N-terminal phosphorylation and acetylation from 8.3 to more than 75% at the branch point 
between eukaryotes and bacteria (Fig. 5). Also, N-terminal phosphorylation in eukaryotes 
highly favors acidic residues in the antepenultimate position (Asp3 or Glu3), with ~50% or 
greater prevalence in eukaryotes, but only ~12.5% prevalence in E. coli and B. subtilis (Fig. 
5). Furthermore, the N-terminal phosphoproteins that contain Asp3 or Glu3 are all acetylated 
at the N-terminus in eukaryotes, with the only exception being C. elegans (42), which has a 
slightly lower coincidence rate of 96% (fig. S3). In summary, bacteria appear to have distinct 
N-terminal phosphorylation preferences, including a high incidence of N-terminal 
phosphorylation at second amino acid position without the first methionine, a low 
co-occurrence of N-terminal acetylation with N-terminal phosphorylation, and a reduced 
prevalence for Glu3 or Asp3 at N-terminal phosphorylation sites. 
 
Discussion 
We addressed the challenging task of comprehensively determining the site-specific 
phosphoproteome in bacteria. In general, extensive fractionation and labor-intensive 
manipulation are required in the field of bacterial phosphoproteomics; however, our newly 
developed protocol is simpler and has the lowest requirement for sample size; these features 
are advantageous for systematic studies of bacterial phosphoregulation. To determine the 
localizations of the phosphosites, we used the site-determining ion combination (SIDIC) 
approach (27), which is based on the presence of a series of site-determining ions in the 
MS/MS spectra, which showed as high as a 97% overlap of high-confidence phosphosites 
with other probability-based algorithms such as PhosClac (Class I) (23), MaxQuant (Class I) 
(24, 25), and Mascot delta score (≥ 9) (26) in the E. coli dataset (table S1.). Based on the 
phosphoproteome maps derived from these three bacteria, the identified phosphoproteins 
were overrepresented in the glycolysis and gluconeogenesis pathways and among ribosomal 
proteins. In terms of protein synthesis, of the 57 proteins in the 70S ribosome, we found that 
28 were phosphorylated. Phosphorylation of these ribosomal proteins might be involved in 
the control of protein translation through conformational changes, protein-protein interactions, 
or alterations in catalytic activity. For example, the phosphosite pSer35 of the S3 
phosphoprotein, which is located in the mRNA-binding avenue of the 30S subunit, is 
proposed to be involved in intermolecular interactions, whereas pSer119 and pSer122 are 
located in the α-helix of domain II, which may direct mRNA binding (43-45). In the large 
subunit, L19 is involved in intersubunit bridge formation between the small and large 
subunits, which is essential for decoding of mRNA code to protein sequence; therefore, 
phosphorylation may have important roles in the processes of subunit assembly and decoding 
(46, 47). The precise mechanisms of ribosomal regulation remain unclear, but our results 
provide some clues to guide further investigations with genetic or biochemical methods. 
 
The largest bacterial phosphoproteome dataset that could be assembled thus far enabled us to 
identify differences in phosphorylation features, including the characteristics of linear 
sequence and position preference, other than residue conservation, between evolutionary 
domains; although detailed phosphoproteome maps of diverse organisms will be needed to 
fully explore these issues. Accordingly, we can propose two alternative mechanisms of kinase 
specificity based on our findings: the first is the surrounding sequence and the second is 
position-based preference. In addition to exhibiting positional preference, bacteria also 
showed an opposing trend in the co-occurrence of N-terminal acetylation with Glu3 or Asp3 
from that in eukaryotes. This low co-occurrence of N-terminal acetylation may at least in part 
be a result of the lower incidence of N-terminal acetylation in bacteria (48), whereas the 
preference for acidic residues in the antepenultimate position may be a result of differences 
between bacterial and eukaryotic kinases. Although we improved the sensitivity of the 
detection of the bacterial phosphoproteome in this study, it is important to note that further 
improvement in detection sensitivity might uncover other bacterial phosphorylation 
preferences, such as a higher degree of N-terminal acetylation or the presence of a 
proline-directed motif, similar to those observed in eukaryotes. Extensive genetic and 
biochemical experiments will be required to establish in detail the mechanisms of molecular 
regulation, as well as to discover species-specific features that might be applied to the design 
of new therapeutic agents to overcome antibiotic resistance. 
 
Materials and Methods 
Cell culture and lysate preparation 
E. coli strain BW25113, B. subtilis strain 168, and K. pneumoniae strain NTUH-K2044 were 
each grown in LB medium (Nacalai Tesque) with vigorous shaking at 37°C. Cells were 
collected by centrifugation at mid-log phase. Cell pellets were resuspended in ice-cold phase 
transfer surfactant (PTSF) buffer containing 100 mM Tris-Cl (pH 9.0), 12 mM sodium 
deoxycholate (Wako), 12 mM sodium lauroyl sarcosinate (Wako), and phosphatase inhibitor 
cocktail (Sigma) (49, 50). Cells were first heated at 95°C for 5 min to inactivate endogenous 
enzymes, the cell wall and cell membrane were then disrupted by sonication, and cellular 
debris and unbroken cells were removed by centrifugation at 30,140g for 30 min at 4°C. To 
remove interfering cellular components, the cell extract was subjected to methanol and 
chloroform precipitation, acetone precipitation, or ultrafiltration before undergoing digestion 
by trypsin. 
 
Methanol and chloroform precipitation 
To the cell lysate was added four volumes of methanol (Wako), followed by an equal volume 
of chloroform (Wako), with thorough mixing. Three volumes of ultrapure water were then 
added. The sample was mixed well and centrifuged at 12,000g for 5 min. The upper aqueous 
phase was carefully removed, and the white protein precipitate that had formed between the 
upper and lower phases was collected. The precipitate was taken up in three volumes of 
methanol and mixed well. Proteins were precipitated by centrifugation at 12,500g for 5 min, 
and the supernatant was completely removed as described previously (51). 
 
Acetone precipitation 
Cell lysates were thoroughly mixed with 5 volumes of ice-cold acetone (Wako), stored 
overnight at -20°C, and then centrifuged at 12,500g for 5 min. The supernatant was 




Cell lysates were placed into an Amicon Ultra-15 device (10-kD, Merck Millipore) and 
centrifuged at 5000g at 4°C until the volume of the concentrate reached about 2 ml. Then, 10 
ml of lysis buffer was added and the mixture was centrifuged. This step was repeated five 
times before trypsin digestion was performed (53). 
 
Protein digestion 
Protein crude extracts without pretreatment were directly reduced with 10 mM dithiothreitol 
(DTT, Wako) at 37°C for 30 min and then alkylated with 50 mM iodoacetamide (Wako) at 
37°C in the dark for 30 min. Alkylated proteins were digested with Lys-C (1:50, w/w, Wako) 
for 3 hours followed by overnight digestion with trypsin at 37°C (1:50, w/w, Promega). The 
surfactants were removed by adding organic solvent as described previously (49). Tryptic 
peptides were dissolved in 5% acetonitrile (ACN, Wako) and 0.1% trifluoroacetic acid (TFA, 
Wako) for desalting with a styrene-divinylbenzene copolymer (SDB-XC) solid-phase 
extraction cartridge (Empore, 3M). In the case of pretreated samples, protein extracts were 
dissolved and denatured in 8 M urea (Invitrogen), which was followed by protein reduction 
and alkylation at room temperature. The alkylated protein was digested with Lys-C for 3 
hours and then diluted four times with 50 mM ammonium bicarbonate (Wako) for overnight 
digestion with trypsin at room temperature. The resulting peptide mixture was acidified with 
TFA and desalted with an SDB-XC solid-phase extraction cartridge. 
 
Phosphopeptide enrichment 
Conventional HAMMOC with titanium dioxide (Titansphere, GL Sciences, Cat. 5020-75010) 
was performed with a 10-μl C8-StageTip as described previously (50). For large-scale 
HAMMOC, a homemade 200-μl C8-StageTip was used; due to backpressure, the flow rate 
was ~10 to 30 μl/min. The amount of TiO2 beads was increased to 1.5 mg, and the sample 
amount was increased to 500 μg for the first trial. For stepwise enrichment, the eluent of the 
large-scale HAMMOC was acidified with TFA and desalted with an SDB-XC StageTip, 
which was followed by conventional HAMMOC enrichment. For phosphopeptide elution, the 
sequential elution approach was adapted with both 0.5 and 5% piperidine (Wako). After 
desalting with an SDB-XC StageTip, phosphopeptides were resuspended in 0.5% TFA, 4% 




The TripleTOF 5600 MS system was coupled with an Ultimate 3000 RSLCnano system 
(Thermo Fisher Scientific) with an HTC-PAL autosampler (CTC Analytics). Peptide 
mixtures were loaded onto a 0.1 mm id× 150 mm long fused-silica capillary column packed 
with C18 material (3 μm, Dr. Maisch GmbH, Amerbuch, Germany). The injection volume for 
peptide samples was 5 μl, and the flow rate was 500 nl/min. The mobile phases consisted of 
solution A of 0.5% acetic acid (Wako) and solution B of 0.5% acetic acid and 80% 
acetonitrile. A three-step linear gradient of 5 to 10% B for 5 min, 10 to 40% B for 60 min, 40 
to 100% B for 5 min, and 100% B for 10 min was used. The MS instrument was operated in 
the positive ion mode, with an ion-spray voltage of 2.3 kV and an interface heater 
temperature of 150°C. Data were acquired from one full MS scan (m/z 300 to 1500) for 250 
ms, which was followed by high-sensitivity MS/MS scans from the top seven most abundant 
precursor ions, each with a 100-ms accumulation time. 
 
Data analysis 
The peak list of each raw MS spectrum was generated as previously described (27). Peptide 
identification was performed by Mascot ver 2.4 (Matrix Science) against a composite 
target-decoy protein sequence database containing 4,316 proteins for E. coli, 5,262 for K. 
pneumoniae, and 4,188 for B. subtilis. The search criteria used in this study were as follows: 
trypsin specificity allowing for up to two missed cleavage events; fixed modification of 
carbamidomethyl (Cys); and variable modifications of oxidation (Met), acetylation (protein 
N-term), and phosphorylation (Ser and Thr), (Tyr), (Asp), and (His). The precursor mass 
tolerance was set at 20 ppm, and the fragment ion tolerance was set at 0.1 Daltons. Data from 
each nanoLC−MS/MS run were searched individually. Peptides were considered identified if 
the Mascot score yielded a confidence limit >95% based on the significance threshold (P < 
0.05) and if at least three successive y- or b-ions with an additional two or more y-, b-, or 
precursor-origin neutral loss ions were observed, based on the error-tolerant peptide sequence 
tag concept (54). These criteria gave a false positive rate of <1% for phosphopeptide 
identification, as evaluated by the target-decoy strategy. For those phosphopeptides identified 
in more than one run, only the phosphopeptides with the highest score were reported. The 
reliability of phosphosite localization was assessed by the site-determining ion combination 
(SIDIC) method (27). To confirm the SIDIC assessment, the site localization probability for 
all E. coli phosphosites was calculated by PhosCalc version 1.2 (23), MaxQuant (24, 25), and 
Mascot delta score (MD-score) (26). Phosphosites with PTM score–based probability by 
PhosCalc or MaxQuant were grouped into Class I (phosphosite probability P > 0.75), Class II 
(0.5 < P ≤ 0.75), and Class III (P ≤ 0.5) (24). Class I phosphosites were accepted 
automatically as unambiguous sites (24). For MD-score, those phosphosites with an 
MD-score of ≥ 9 (99% accuracy) were considered as unambiguous sites. 
 
Motif-X analysis 
All confirmed phosphosites were used as input for Motif-x software to determine motifs for 
these phosphorylated substrates with the proteome as background (55). Parameters for the 
Motif-x analyses were as follows: foreground central residue = S or T or Y (depending on the 
analysis), width = 13, the number of occurrences was 10, and the statistical significance was 
0.00001, unless otherwise stated. 
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Fig. 1. Comparison of phosphopeptide enrichment efficiencies. (A) Samples of E. coli 
were subjected to conventional or large-scale HAMMOC without pretreatment or else were 
pretreated by acetone precipitation, ultrafiltration, or precipitation with methanol and 
chloroform (MeOH/CHCl3) before being subjected to large-scale HAMMOC. Bars represent 
the number of identified phosphopeptides by duplicate LCMS injections from the same 
enriched samples. Tryptic peptides from lysates (500 µg) were used for large-scale 
HAMMOC, whereas 100 µg of sample was used for conventional HAMMOC. (B) Sample 
capacity test of large-scale HAMMOC. The amount of peptide used for the analysis ranged 
from 500 to 1,000 µg, as indicated. Paired bars show the numbers of identified 
phosphopeptides and represent duplicate samples and handling, including protein 
precipitation, trypsin digestion, phosphopeptide enrichment, and LC-MS/MS measurement. 
 
Fig. 2. Overlap of E. coli phosphoproteomes. (A to C) Analysis of the overlap in the 
numbers of (A) phosphopeptides, (B) phosphoproteins, and (C) phosphorylated ribosomal 
proteins identified in E. coli in the current study and those in published E. coli 
phosphoproteomes (9, 10). 
 
Fig. 3. Overview of the E. coli phosphoproteome. (A) The percentage of identified 
phosphoproteins assigned to essential genes according to the Ecogene Database annotation. 
(B) Gene ontology (GO) distribution of identified phosphoproteins with respect to biological 
processes and cellular components with the DAVID Functional Annotation tools. The 
percentages indicate those proteins that belong to distinct categories. (C and D) 
Phosphoproteins participate widely in housekeeping pathways based on the KEGG database, 
including (C) the glycolysis and gluconeogenesis pathways and (D) ribosomal proteins. Blue 
circles in (C) represent phosphoproteins identified in E. coli, K. pneumoniae, or B. subtilis. 
White circles or boxes in (C) and (D) indicate unphosphorylated proteins in distinct pathways. 
The colored boxes in (D) indicate the phosphorylated ribosomal proteins that were observed 
in this study. (E) Frequency distribution analyzed by Sequence Logo Generator 
(http://www.phosphosite.org/) (56) of the general representation of residues surrounding the 
phosphorylated tyrosine residue based on data from a previous study (30) and from the 
current study. 
 Fig. 4. Statistically significantly enriched phosphorylation motifs of bacterial 
phosphoproteomes obtained by Motif-x analysis. Motif-x software was used to represent 
the N- or C-terminal position, but not any particular amino acid, with the three proteomes as 
background. Three motifs are overrepresented in the large-scale phosphoproteomic maps. (A) 
The linear sequence with lysine (K) at the -1 position relative to serine (S, left) and threonine 
(T, right) is preferred in bacteria. (B) Three position-directed motifs in which a phosphosite 
near the N or C terminus of the protein is statistically significantly enriched. The parameters 
of the Motif-x algorithm were occurrences = 10 and significance = 0.00001. 
 
Fig. 5. Co-occurrence of N-terminal phosphorylation with N-terminal acetylation, and 
analysis of adjacent acidic residues in the antepenultimate position of 11 evolutionarily 
divergent organisms. The phosphoproteomes of evolutionarily divergent organisms were 
collected from the literature and our own datasets (12, 38-42). Bars represent the numbers of 
pSer2- or pThr2-containing proteins divided by the total number of phosphoproteins. The 
white portion of the bar shows the proportion of N-terminal phosphoproteins that underwent 
N-terminal acetylation, whereas the black portion indicates the proportion of N-terminal 
phosphoproteins that were not acetylated. Each bar was normalized by the relative value of 
the Ser2 and Thr2 content in the total proteins of each indicated organism to the Ser2 and Thr2 
content of E. coli. The gray curve represents the number of N-terminal phosphoproteins that 
contain Asp3 or Glu3 as a percentage of the total number of N-terminal phosphoproteins. The 
numbers in parentheses below the x-axis denote the total number of proteins in each organism. 
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